Reactivation of tuberculosis following ruxolitinib therapy for primary myelofibrosis: Case series and literature review

Reactivation of tuberculosis following ruxolitinib therapy for primary myelofibrosis: Case series and literature review

Primary myelofibrosis (PMF) is a subtype of BCR-ABL1 negative myeloproliferative neoplasm. Its characteristic features include clonal myeloproliferation, dysregulation of kinase signaling pathway, abnormal release of cytokines leading to fibrosis in the bone marrow, osteosclerosis, and extramedullar...

Full description

Bibliographic Details
Main Authors: Farhan Khalid, Moussab Damlaj, Mohsen AlZahrani, Khadega A. Abuelgasim, Giamal Edin Gmati
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Hematology/Oncology and Stem Cell Therapy
Subjects:
JAK2
Myelofibrosis
Ruxolitinib
Tuberculosis
Online Access:http://www.sciencedirect.com/science/article/pii/S1658387620300327

Internet

http://www.sciencedirect.com/science/article/pii/S1658387620300327

Similar Items